Our Goal of a Non-Invasive Prickless Blood Glucose Level Monitor is Within Reach


KEY FACTS

  • 5,000 Americans will be digonsed with Diabetes today.
  • Diabetes will cost America $476 Million in the next 24 hours alone.
  • 7 million Americans woke up with Diabetes and they do not know it yet.
  • 79 million U.S. citizens have prediabetes.
  • Diabetes is the leading cause of kidney failure, nontraumatic lower limb amputations, and new cases of blindness among adults in the United States.
  • In 2010 there were 230,000 deaths in the U.S. in which diabetes appeared as any-listed cause of death.
  • In 2011, the estimated diabetes costs in the U.S. totaled $218 billion which includes direct medical costs and indirect costs including disability, work loss, and premature mortality.
  • Due to the fact the finger prick device is the only cost effective SMBG device available today, it is reported that only a 33% testing compliance rate is achieved[1].
[1] Diabetes Care August 2001 24: 1502-1503
Alethus, Inc., a Cambridge, MA based company, is developing the world's first noninvasive device for diabetes patients to monitor their glucose level in a bloodless and painless manner This will allow diabetics to measure their glucose levels as many times as they want to each and every day without pricking their finger once. Self-monitoring of blood glucose levels is crucial to glycemic control and to reduce or avoid complications.
© 2014 Alethus - All rights reserved.